The pharmaceutical industry is energizing its approach to patient engagement, adopting a patient-centric philosophy that prioritizes involving patients in a meaningful way throughout the drug development lifecycle. But there is still a lot of room for growth – in a 2019 study, only 47% of patients said they felt pharmaceutical companies understood their emotional, financial, and other needs related to their condition, and only a third reported interacting with a pharmaceutical company on a regular basis.

We’ve compiled some of our best practices around over-time virtual patient engagement for pharmaceutical organizations that will help medical affairs, clinical/R&D, and commercial teams get high-quality insights. In this paper, we’ll discuss:

• Choosing the right participants – both patients and moderators
• Tips for conducting blind or double-blind sessions
• Choosing the right questions to prompt robust discussion
• How to maintain confidentiality
• Real-world examples of patient engagement success